-
-
-
-
-
-
-
UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations
-
-
-
-
-
-
-
ScoutCam receives $2 million investment from Mori Arkin, a leading life science and pharmaceutical entrepreneur
-
-
-
-
-
-
-
UroGen Reports Fourth Quarter and Full Year 2017 Financial Results
-
-
-
-
-
-
-
UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors
-
1,160,151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

